Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), NEJM study shows are mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock opened today at $35.55 and is currently trading at $35.27. The stock showed a positive weekly performance of 2.52%.
Geron Corporation (NASDAQ:GERN) announcing on 13 June that the FDA has lifted the partial clinical hold on an investigator-sponsored study of imetelstat. The investigator provided follow-up information regarding the reversibility of hepatotoxicity for all patients who received imetelstat in the study in order to get the partial clinical hold lifted. Geron Corporation (NASDAQ:GERN) stock opened at $3.20, in current trading session and currently is at $3.18, by gaining 1.92%. The 52 week range of $1.11 – $7.79. Company’s market capitalization is 499.05 million.
The business model of FuelCell energy Inc. (NASDAQ:FCEL) differentiates it from Plug Power and Ballard Power Systems. Growing demand for clean energy should allow the company to exploit this market over the next few years. The services contracts will allow FuelCell energy to have a stream of revenues which will result in more stability compared to the other players in the sector. FuelCell Energy Inc. (NASDAQ:FCEL) stock is currently trading at $2.58. The EPS of the stock is -0.22. Company’s market capitalization is 661.58 million.
Black Diamond Inc. (NASDAQ:BDE), a supplier of active outdoor performance equipment and apparel, said that it has signed a definitive asset purchase agreement to sell its Gregory Mountain Products, LLC brand for $85 million to Samsonite LLC. The transaction is subject to customary closing conditions and expected to close in late July 2014. Black Diamond Inc. (NASDAQ:BDE) stock opened the session at $12.03, and now is at $12.32. The 52 week range of the Black Diamond Inc. (NASDAQ:BDE) stock remained $8.99 – $15.15 and the day range was $12.03 – $12.60.
Cannabis-based drug maker GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) is to raise $148m (£87m) from US investors to advance its treatment for severe childhood epilepsy. The company will rake in $104.2m from the current round since around a third of the offer consists of existing shares held by a number of the company’s directors. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) stock opened today at $88.93 and is currently trading at $88.57. The stock showed a positive weekly performance of 15.57%.